Viewing Study NCT03443492


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-01-01 @ 11:14 PM
Study NCT ID: NCT03443492
Status: COMPLETED
Last Update Posted: 2025-02-10
First Post: 2018-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SLOG Vs MFOLFIRINOX As the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer
Sponsor: National Health Research Institutes, Taiwan
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module